MA45580A - Titrage basal avec glycémie cible adaptative - Google Patents

Titrage basal avec glycémie cible adaptative

Info

Publication number
MA45580A
MA45580A MA045580A MA45580A MA45580A MA 45580 A MA45580 A MA 45580A MA 045580 A MA045580 A MA 045580A MA 45580 A MA45580 A MA 45580A MA 45580 A MA45580 A MA 45580A
Authority
MA
Morocco
Prior art keywords
adaptive target
basal titration
target glycemia
glycemia
titration
Prior art date
Application number
MA045580A
Other languages
English (en)
Inventor
Tinna Björk Aradóttir
Henrik Bengtsson
Pete Brockmeier
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA45580A publication Critical patent/MA45580A/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2093—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically including concentration setting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3306—Optical measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6054—Magnetic identification systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/005—Parameter used as control input for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/50—Temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Psychiatry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
MA045580A 2016-07-08 2017-06-23 Titrage basal avec glycémie cible adaptative MA45580A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16178554 2016-07-08

Publications (1)

Publication Number Publication Date
MA45580A true MA45580A (fr) 2019-05-15

Family

ID=56464025

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045580A MA45580A (fr) 2016-07-08 2017-06-23 Titrage basal avec glycémie cible adaptative

Country Status (6)

Country Link
US (1) US11373746B2 (fr)
EP (1) EP3481274B1 (fr)
JP (1) JP6756030B2 (fr)
CN (1) CN109661196B (fr)
MA (1) MA45580A (fr)
WO (1) WO2018007172A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020002428A1 (fr) * 2018-06-26 2020-01-02 Novo Nordisk A/S Système fournissant des recommandations de dose pour le titrage de l'insuline basale
US11967407B2 (en) * 2018-07-26 2024-04-23 Sanofi Method of adjusting medication doses
EP4042435A1 (fr) * 2019-10-11 2022-08-17 Bigfoot Biomedical, Inc. Ajustement du réglage d'une thérapie à l'insuline sur la base de la variabilité des valeurs de glycémie
WO2021113859A1 (fr) * 2019-12-03 2021-06-10 Bigfoot Biomedical, Inc. Détermination du fait que des ajustements de recommandations d'insulinothérapie sont pris en compte
WO2022234032A2 (fr) * 2021-05-05 2022-11-10 Novo Nordisk A/S Méthodes et systèmes d'estimation de valeurs de glucose à jeun
CN114081484B (zh) * 2021-11-24 2024-02-27 上海微创生命科技有限公司 连续血糖检测方法、系统及可读存储介质
WO2023144364A1 (fr) 2022-01-31 2023-08-03 Novo Nordisk A/S Systèmes et procédés de titrage d'insuline personnalisé

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11296598A (ja) 1998-04-07 1999-10-29 Seizaburo Arita 血糖値の予測システム及び予測方法並びにこの方法を記録した記録媒体
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6883521B2 (en) 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2005113036A1 (fr) * 2004-05-13 2005-12-01 The Regents Of The University Of California Procede et dispositif de regulation du glucose et de dosage de l'insuline pour des sujets diabetiques
US7291107B2 (en) 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
GB2436873A (en) 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
WO2009001349A1 (fr) 2007-06-25 2008-12-31 Medingo Ltd. Système d'administration d'insuline basale personnalisé
EP2260423B1 (fr) * 2008-04-04 2018-02-28 Hygieia, Inc. Appareil pour optimiser un régime posologique d'insuline d'un patient
US8480649B2 (en) 2008-04-29 2013-07-09 Ofer Yodfat Method for selecting bolus doses and bolus delivery patterns in a drug delivery device
WO2009146445A1 (fr) 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Procédé et système fournissant un contrôle glycémique
US8527208B2 (en) * 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
BRPI1008842B1 (pt) 2009-02-04 2021-04-13 Sanofi-Aventis Deutschland Gmbh Dispositivo e método médicos para proporcionarem um controle glicêmico com base em informações de resposta glicêmica
CN102334113B (zh) 2009-02-25 2016-01-13 弗吉尼亚大学专利基金会 通过低血糖风险评估和平滑降低胰岛素递送的基于cgm的低血糖预防
US8532933B2 (en) * 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
WO2012058694A2 (fr) 2010-10-31 2012-05-03 Trustees Of Boston University Système de régulation de la glycémie
CN103782298A (zh) 2011-05-06 2014-05-07 诺沃-诺迪斯克有限公司 用于随时间的推移优化药物配药方案的系统
CA2846854C (fr) 2011-08-26 2022-12-13 University Of Virginia Patent Foundation Procede, systeme et support lisible par ordinateur pour la regulation adaptative conseillee du diabete
US20130338630A1 (en) 2012-06-07 2013-12-19 Medtronic Minimed, Inc. Diabetes therapy management system for recommending adjustments to an insulin infusion device
ES2710250T3 (es) 2012-08-24 2019-04-23 Hoffmann La Roche Bomba de insulina y métodos de funcionamiento de la bomba de insulina
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
DK3409201T3 (da) 2013-03-15 2024-07-15 Abbott Diabetes Care Inc System og fremgangsmåde til håndtering af diabetes baseret på glucosemedian, glucosevariabilitet og hypoglykæmisk risiko
EP3011487B1 (fr) 2013-06-21 2023-09-27 Fresenius Vial SAS Procédé et dispositif de commande pour commander l'administration d'insuline à un patient
CN113940627A (zh) 2013-08-05 2022-01-18 海吉雅有限公司 减轻糖毒性和恢复胰岛β细胞功能的系统、装置和方法
AU2015100005A4 (en) 2014-01-27 2015-02-12 Digital Medics Pty. Ltd. Diabetic Connect Bluetooth Adaptor

Also Published As

Publication number Publication date
EP3481274A1 (fr) 2019-05-15
JP2019531522A (ja) 2019-10-31
EP3481274B1 (fr) 2023-01-25
WO2018007172A1 (fr) 2018-01-11
US20190147999A1 (en) 2019-05-16
CN109661196A (zh) 2019-04-19
CN109661196B (zh) 2022-03-29
US11373746B2 (en) 2022-06-28
JP6756030B2 (ja) 2020-09-16

Similar Documents

Publication Publication Date Title
MA45580A (fr) Titrage basal avec glycémie cible adaptative
DK3475433T3 (da) Adenoviral vektor
BE1022358A1 (nl) Sputterinrichting met bewegend doelwit
DE112016005194A5 (de) Aktor
BR112017022231A2 (pt) atuadores de onda
DK3625104T3 (da) Ukrudtsbekæmpelse ved høj hastighed
GB201511007D0 (en) Nozzle assembly with adaptive closed signal
DK3601785T3 (da) Belægning
BR112017026299A2 (pt) conjunto e embarcação
MA49422A (fr) Titrage basal avec glycémie cible adaptative
DE112017005261A5 (de) Stiftofen
DK3397327T3 (da) Sprøjte med klikmekanisme
FR3046674B1 (fr) Machine de lancement de cibles avec barillet ameliore
ITUA20162057A1 (it) Natante
ES1158985Y (es) Conjunto de aparato ocultable
DK3464051T3 (da) Tårnmontage
FR3026479B1 (fr) Lance missile
MA50507A (fr) Construction de vecteur
DE112017005260A5 (de) Stiftofen
FI11369U1 (fi) Luukku
ITUA20162490A1 (it) Attuatore per esoscheletro
FI20155818A (fi) Järjestely työkoneen nivelliitoksessa
UA32589S (uk) Накривка розприскувача
ES1176109Y (es) Cebador de pesca
CL2018002944S1 (es) Buque